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ABSTRACT 
Introduction 
Cardiovascular risk (CVR) assessment and management in patients with inflammatory arthritis (IA) is 
recommended, but European nurses’ involvement in this role has not been well-studied. 
Aim  
To explore European nurses’ role in assessing and managing CVR, in order to suggest topics for practice 
development and research in this area regarding persons with IA.  
Methods 
We searched Embase, Cinahl, Cochrane, PsycInfo and PubMed databases and included European articles 
from the past 10 years if they described how nurses assess and/or manage CVR. In addition to the 
systematic review, we provided case studies from five different countries to illustrate national guidelines 
and nurses’ role regarding CVR assessment and management in patients with IA. 
Results 
Thirty-three articles were included. Trained nurses are undertaking CVR assessment and management in 
different settings and groups of patients. The assessments include blood pressure, body mass index, waist 
circumference, glucose and lipid-profile, adherence to medication and behavioural risk factors (unhealthy 
diet, physical inactivity, alcohol and smoking). Different tools were used to calculate the patients’ risk. 
Risk management differed from brief advice to long-term follow-up. Nurses tend to take a holistic and 
individually tailored approach. Clinical examples of inclusion of rheumatology nurses in these tasks are 
scarce. 
Conclusion 
Nurses undertake CVR assessment, communication and management in different types of patients. This is 
considered to be a highly relevant task for rheumatology nursing, especially in patients with IA. Further 
studies are needed to assess the patients’ perspective, effectiveness and cost-effectiveness of nurse-led 
CVR. 
Keywords: Inflammatory arthritis, cardiovascular risk, nurse-led, consultations 
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INTRODUCTION 
It is well known that people with rheumatoid arthritis (RA) have higher mortality compared to the general 
population and primarily due to an increased risk of cardiovascular (CV) events (Avina-Zubieta et al. 
2012, Gullick and Scott 2011, Meune et al. 2009, Meune et al. 2010).  The excess CV risk (CVR) appears 
to be caused by both the inflammatory process and an increased prevalence of some of the traditional risk 
factors for development of CV disease (del Rincon et al. 2001, Innala et al. 2011, Solomon et al. 2010).  
In 2010 the European League Against Rheumatism (EULAR) published recommendations for CVR 
management (Peters et al. 2010), which advocated screening and CVR assessment in all patients with RA 
according to local guidelines or with the systematic coronary risk evaluation (SCORE) system. SCORE is 
a multiple traditional risk factor assessment equation based on gender, smoking, age, systolic blood 
pressure and total-/High Density Lipoprotein (HDL) cholesterol ratio (Peters et al. 2010, Conroy et al. 
2003). In order to adjust for the extra risk in patients with RA, this SCORE should be adapted by a 
multiplication factor of 1.5 if the patient meets two of the following three criteria: a) disease duration ≥ 10 
years; b) rheumatoid factor and/or anticyclic citrullinated peptide (anti-CCP) positivity; and c) the 
presence of certain extra-articular manifestations, thereby creating the modified mSCORE (Crowson et al. 
2012, Peters et al. 2010). A focus on controlling the patients’ disease activity is also very important in 
order to lower the patient’s risk for CV disease (Peters et al. 2010). When the EULAR guidelines for 
CVR management were published in 2010 (Peters et al. 2010), there was limited evidence for patients 
with Ankylosing Spondylitis (AS) and Psoriatic Arthritis (PsA). Later studies have supplemented the 
evidence for an increased risk for them as well, although the evidence that inflammation affects the risk 
for ischemic heart disease is less conclusive than in RA (Ernste et al. 2015, Jamnitski et al. 2011, 
Papagoras et al. 2013, Khraishi et al. 2014, Mathieu et al. 2014, Parisi et al. 2015, Wright et al. 2014, 
Essers et al. 2014) 
CVR assessment and management in people with different types of medical conditions involve different 
health professionals, but across the world nurses in different settings are increasingly undertaking this 
task (Olde et al. 2013, Rice et al. 2013, Nieuwkerk et al. 2012, Boase et al. 2012, Deaton et al. 2011, 
Berra 2011, Osborn et al. 2010, Morris et al. 2009, Fair et al. 2009, Jansink et al. 2009, Hoebeke 2008).  
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EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis 
(IA) (van Eijk-Hustings et al. 2012) encourage nurses to carry out interventions and monitoring as part of 
comprehensive disease management in these patients. These recommendations also identified the need to 
define the contribution of the nurse in the prevention of comorbidities in patients with IA (van Eijk-
Hustings et al. 2012).  
The aim of this paper was to explore nurses’ role in assessing and managing CVR in Europe, in order to 
suggest topics for practice development and research in this area regarding persons with IA.  
METHODS 
We conducted a systematic literature review and provided practical examples of CVR assessment and 
management in patients with IA in five European countries. The questions that guided the literature 
search were (i) how do nurses assess CVR in Europe? and (ii) how do nurses manage CVR in Europe? 
The literature review is followed by case studies from five different countries to illustrate national 
guidelines and nurses’ role regarding CVR assessment and management in patients with IA. 
Literature review 
Literature search 
We searched five electronic databases supplemented by a hand search in the reference lists of the 
included articles. In Embase, CINAHL, Cochrane and PsycInfo we used the search terms: “nurs*” AND 
“cardiovascular risk” and in PubMed MEDLINE we used “cardiovascular risk” AND the MeSH term for 
“nursing”. The searches were limited to full text, and to the past 10 years in order to represent recent 
practice. The inclusion criteria were: (i) studies from Europe, (ii) published from June 2004 through June 
2014, (iii) studies reporting descriptions of nurse-led assessment and or management of CVR. Studies 
were excluded if they only described a protocol, involved children or adolescents or were written in 
languages other than English, Portuguese, Spanish, Italian, French, Swedish, Norwegian or Danish. 
Duplicates were discarded. In March 2015 the searches were updated in order to identify relevant articles 
published from June 2014 through February 2015.  
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Study selection 
Two reviewers (RF and JP) independently screened the titles and abstracts according to the selection 
criteria. In the screening process, disagreements were discussed until consensus was reached. The articles 
selected for full text screening were divided between five reviewers (JP, RF, SG, MN and YvE). Each 
reviewer screened the full texts independently and made a judgement for inclusion/exclusion and 
documented their reasons based on the predefined inclusion/exclusion criteria. Where the reviewer had 
doubts, the article was assessed by a second reviewer too before inclusion. Finally the list of included 
articles was discussed among all authors in order to achieve agreement.  
Data extraction  
Data extraction was performed using a predefined data extraction form which included: authors, journal, 
title, publishing date, type of study, number of patients included, medical diagnoses or risks, content of 
the nurse-led risk assessment and, if done, how nurses managed the identified risk factors. Data extraction 
was performed independently by each reviewer and then two reviewers (RF and YvE) independently 
checked the accuracy of the data against the included articles. The data from these forms were 
synthesized descriptively. See Table 1.  
RESULTS 
Of the 65 eligible articles, 25 satisfied the inclusion criteria and three were added via hand search. 
Through the updated search we identified five additional articles, resulting in a total of 33 included 
articles (Figure 1). 
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Pubmed MEDLINE 
(n = 233) 
EMBASE  
(n =250) 
Records obtained 
(n = 878) 
Records screened 
(n =766) 
Records duplicated  
(n = 112) 
Full-text articles assessed for 
eligibility (n =65) 
Full-text articles excluded    (n 
=40)  
• 15 Non-European 
• 25 Article type 
Articles included in qualitative 
synthesis (n =33) 
COCHRANE  
(n =239) 
Articles added by hand search 
(n=3)  
Articles added by review update 
(n=5) 
(n=8) 
CINAHL  
(n =98) 
Psycinfo 
(n =58) 
Figure 1: Flowchart of the literature search and inclusion of articles 
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Characteristics of included studies 
The 33 articles represent 30 different studies which are summarised in Table 1. Seventeen of the included 
articles report results from 14 Randomized Controlled Trials (RCT); eight report cross-sectional studies; 
three pre-test post-test studies, three discursive articles and two qualitative studies. 
The settings of nurse-led assessment of CVR  
The included clinical studies showed that European nurses undertake CVR assessment in many different 
settings such as primary health care (general practice and or in the community) (n=16) or in hospitals 
(n=15). 
Type of patients 
Apart from assessment of CVR in the general population (n=3), nurses also undertake risk assessment in 
patients with one or more already known elevated CVR factors (n=12), known CV diseases (n=5) and in 
patients with a specific increased risk such as chronic kidney disease (n=4), diabetes (n=2), psychiatric 
diseases (n=2) or rheumatoid arthritis (n=2).  
The content of the nurse-led risk assessments  
The included studies describe that nurses usually perform a general risk assessment and check whether 
treatment goals are achieved (Table 1). The variables included in the nurses’ general CVR assessments 
usually follow recommendations from the national associations for General Practitioners (GPs), 
hypertension, diabetes or cardiology associations.  
The nurses risk assessment includes the measurement of resting blood-pressure (BP) (sitting in a chair 
and after at least 5 minutes rest) and lipids (all or some of the following: total-, High Density Lipoprotein 
(HDL)-, Low Density Lipoprotein (LDL)-cholesterol and Triglycerides). In addition, the nurses often 
assess behavioural risk factors (unhealthy diet, physical inactivity, excess alcohol and smoking), 
overweight and obesity estimated by Body Mass Index (BMI) and in some cases also waist circumference 
(Table 1). In three studies the nurses assess both waist and hip circumference (#1, 23 and 28) and 
calculate a waist/hip ratio. Family history of or known ischemic CV disease and known diabetes or are 
often included in the nurses’ assessment as well as glucose level. In four studies the presence of metabolic 
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syndrome was assessed (including assessment of abdominal obesity or waist circumference, atherogenic 
dyslipidaemia, increased BP and insulin resistance) (#6, 16, 28 and 29). Homocysteine level and/or 
coagulation profile was included in a few studies (#29 and 31). The assessment of stress was described in 
two of the studies and ankle brachial index in one study (#16).  In addition more disease specific 
measures such as thyroid (#11 and 18), kidney function (#27, 28 and 32), left ventricular hypertrophy 
(#24) or heart rate (#29) were assessed depending on the type of patients. In this article we will not focus 
further on these disease specific assessments. 
It is also described that nurses assess the patients’ motivation for change in risk-related behaviour (#4, 10, 
11, 23, 29 and 32), socioeconomic status (#10 and 17) or educational level (#6), and the availability of 
health services for further support (#4 and 10) (Table 1). 
In one study (#17), nurses used additional questionnaires to assess saturated fat, fruit and vegetable intake 
and physical exercise. In one study the nurses assessed the participants’ risk perception and anxiety (#17), 
and two studies described the assessment of satisfaction or confidence in decisions (#17 and 19).  
Risk calculation 
Different tools were used to calculate the patients´ absolute risk for CV death in 10 years, being the 
European SCORE system the most used (n=8). See Table 1. Other tools used were the Framingham (n=4) 
and the modified Framingham (n=1) and the UK Prospective Diabetes Study Risk engine for diabetic 
patients (n=1).  
Nurse-led interventions and management of patients’ CVR 
Nurses’ role in the management of patients’ CVR in Europe varied in the identified studies, from brief 
advice to comprehensive and long-term follow-up. Different roles were described regarding the patients’ 
pharmacological therapy (Table 1) such as creating an overview over the patients’ current medication, 
their preference for medication, adherence or compliance to CVR therapy as well as other types of 
medication. While in some studies nurses titrated antihypertensive or cholesterol lowering medications 
(#5, 11, 19 and 25), in others, the results of the nurse assessments were used as a basis for initiation or 
titration of pharmacological therapy by the rheumatologist or GP (#4 and 8).  
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The nurses’ approach is mainly described as being holistic, individually tailored and based on shared 
decision making. Nurses aim to empower the patient or increase the patients’ self-management abilities or 
self-efficacy and to take ownership of their risk. 
The nurses offer education, additional information materials (in different formats such as leaflets and 
DVDs), individualized advice and coaching regarding healthy low fat balanced diet, how to lose weight, 
increase physical activity, reduce alcohol consumption, smoking cessation, adherence to medication and 
risk perception. Motivational Interviewing is described as a common tool used in discussions regarding 
life-style (#5, 11, 12, 17 and 20). Nurses also help patients set realistic and achievable goals and how to 
evaluate them. Some of the included studies describe that the participants were offered additional tools 
such as a weighing scale and a pedometer (#11), a health booklet (#19) or a sheet with the risk assessment 
results (#4 and 7). Two of the studies underline that the nurses aimed to involve the patients’ partner or 
family in the education provided (#24 and 26). 
One of the major roles for the nurses is referring people with increased risk, due to one or several risk 
factors, to other available health care resources (Table 1). 
Education of nurses who perform risk assessment and risk management 
In some of the included studies the nurses, who were undertaking CVR assessment and or management, 
had received short training in advance. The training included Motivational Interviewing, shared decision-
making, risk assessment, risk communication, and the distribution of decision aids (#4, 5, 15, 17 and 20). 
Video recordings of the nurses’ consultations are used in one study in order to provide feedback by 
medical psychologists (#5).  
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Table 1: Data extraction form 
Author (year)  
Country 
Study 
type 
Number and  
type of patients 
Risk assessment 
components 
Risk 
scoring  
Risk management components 
1. Frei, A. et al. 
(2014) 
Switzerland 
RCT 326 primary care 
patients with type 2 
DM  
Waist/hip ratio, BMI, 
glucose level, BP, total-, 
HDL- and LDL-cholesterol, 
smoking, antidiabetic 
medication  
None How: Self-management support and 
monitoring  
What: Clinical parameters (e.g., 
HbA1c), examinations (e.g., food 
control), adherence to medications, 
self-care goals, and other 
recommendations 
2. Korhonen, P. et 
al. (2014) 
Finland 
Pre-test 
post-test 
2752 primary care 
patients with at 
least one CVR 
factor 
A + WC, BMI, glucose 
level, history (DM, 
hypertension), medication, 
family history CVD, 
alcohol, diabetes risk score 
(FINDRISC), leisure-time 
physical activity  
SCORE How: Patient education (verbal and 
written), referral to physician (within 
specified criteria) 
What: Lifestyle advice (diet and 
physical activity) and explanation of 
test results  
3. Dougados, M. 
et al. (2014) 
France 
RCT 970 outpatients 
with RA 
 
B+ BMI, diet, history 
(CVD, DM, hypertension), 
family history of CVD, 
medication  
 
mFraming
ham 
 
How: Patient education and lifestyle 
advice, report to GP or R and referral 
(within specified criteria) 
What: comorbidity management (eg. 
importance BP self-measurement by 
purchasing a BP device)  
4. Primdahl, J. et 
al. (2013)  
Denmark 
Cross-
Sectional 
836 outpatients 
with RA 
A + WC, BMI, glucose 
level, physical activity, 
alcohol, medication, family 
history (CVD and DM), 
history (hypertension, DM 
or CVD) 
SCORE 
and 
mSCORE 
How: Patient education (verbal and 
written) and training, referral to GP 
and/or to community health care centres 
What: Discussing findings with 
patient, lifestyle advice (eg. smoking, 
alcohol, physical activity, diet), 
education regarding RA 
5. Jorstad, H. et 
al. (2013)  
The Netherlands 
RCT 754 patients with 
acute coronary 
syndrome 
A, B + glucose level, WC, 
diet, physical activity, 
medication, stress, CVD 
history, ethnicity 
SCORE 
and 
Framingh
am 
How: Patient education (verbal and 
written), referral to GP or specialist or 
other HP (within specified criteria), 
titration of medication (protocolled, 
Motivational Interviewing 
What: Lifestyle advice (eg. diet, 
smoking, physical exercise and 
weight/fat distribution), medication 
adherence) 
6. Morales-
Asencio, J. et al. 
(2013)  
Spain 
Cross-
sectional  
2270 general 
population 
WC, BMI, glucose level, 
BP, full lipid profile, 
metabolic syndrome*, 
CVD, smoking, physical 
activity, level of education 
None NA 
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7. Dedoncker, A. 
et al. (2012) 
France 
Pre-test 
post-test  
50 patients 
hospitalized 
following a 
coronary artery 
bypass  
BMI, glucose level, BP, full 
lipid profile, physical 
activity, diet, smoking, 
history of CVD 
None How: Patient education (individual 
consultations) before cardiac 
rehabilitation discharge, personalized 
form summarizing tertiary prevention 
goals 
What: Lifestyle factors advice, setting 
specific goals. 
8. Mohammed, 
M. et al. (2012) 
UK 
RCT 
(secondary 
analyses) 
500 patients with 
high CVR (>20% 
on Framingham) 
eligible for statin 
and 
antihypertensive 
treatment 
B + (family) history CVD, 
DM, preference for 
medication, ethnicity  
Framingh
am 
How: Referral to GP for prescription of 
antihypertensive or statin 
What: Decision of medication 
necessity 
9. Boase, S. et al. 
(2012) 
UK 
Qualitative Two focus-groups 
(6+6) and 16 
interviews with 
primary care nurses  
NA 
 
NA How: Tailored approach 
What: Lifestyle advice (CVR factors) 
10. Andric, A. & 
Vuletic, S.(2012) 
Croatia 
Qualitative 253 patients with 
increased CVD risk 
BMI, BP, DM, diet, 
physical inactivity, alcohol, 
smoking, general health, 
history of CVD 
NA How: Conceptual model for CVR 
management  
What: Behavioural CVR factors 
11. Tiessen, A. et 
al.  (2012)  
The Netherlands 
RCT 179 patients 
without CVD or 
diabetes but with 10 
year CVR > 5% (on 
SCORE) and at 
least 1 treatable risk 
factor 
A + BMI, WC, glucose 
level, physical activity, 
family history, history of 
CVD, medication 
SCORE How: Counselling (Motivational 
Interviewing), feedback based on self-
monitoring results (pedometer, 
weighting scale and/or BP device), 
treatment/support regarding specific 
risk factors, follow-up 
What: CVR factors (overweight, 
smoking, physical activity, 
hypertension and hypercholesterolemia) 
12. Van Zuilen, 
A. et al. (2012) 
The Netherlands 
RCT 788 patients with 
chronic kidney 
disease 
BMI, glucose level, BP, full 
lipid profile, smoking, 
physical activity, history of 
CVD, DM, medication  
None How: Life-style coaching using 
Motivational Interviewing, intensive 
control (added to nephrologist care)  
What: CVR factors, adherence to CVD 
medication  
13. Driehuis, F. et 
al. (2012) 
The Netherlands 
RCT 457 patients with 
hypertension and/or 
dyslipidaemia (aged 
40 to 70 years, BMI  
25 to 40)  
BMI, physical activity, diet None How: Counselling and feedback 
consultation 
What: Physical activity and dietary 
intake 
14. Van Zuilen, 
A. et al. (2011) 
The Netherlands 
RCT  
(interim-
analysis of 
study #12) 
692 patients with 
chronic kidney 
disease 
 (please see #12) None (please see #12) 
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15. Koelewijn-
van Loon, M. et 
al. (2011) 
The Netherlands 
Cross-
sectional 
(nested in a 
clustered 
RCT #17 
and 22) 
421 patients eligible 
for CVR 
management 
A + BMI, family history of 
CVD, alcohol, diet, physical 
activity 
SCORE NA 
16. Benítez, C. et 
al. (2010)  
Spain 
Cross-
sectional  
73 patients with 
chronic kidney 
disease at 
haemodialysis  
BMI, BP, WC, ABPI, CVD, 
DM, metabolic syndrome*, 
alcohol, diet, smoking, 
physical activity, stress 
None NA 
17. Koelewijn-
van Loon, M. et 
al. (2010) 
The Netherlands 
RCT 589 patients eligible 
for CVR 
management 
(without CVD) 
(please see #15) SCORE 
and the 
UK 
Prospectiv
e Diabetes 
Study 
Risk 
engine for 
diabetic 
patients 
How: Counselling and Motivational 
Interviewing, risk communication using 
a decision tool  
What: CVR factors, risk perception, 
confidence and satisfaction using the 
decision tool 
18. Martos-
Cerezuela, I. et al. 
(2010)  
Spain 
 
Cross-
sectional  
 
2270 primary care 
patients  
 
 
BMI, WC, BP, glucose 
level, cholesterol 
 
None 
 
NA 
 
19. Osborn, D. et 
al. (2010) 
UK 
RCT 6 community 
mental health teams 
and 161 outpatients 
with severe mental 
illness  
B + BMI, glucose level. Framingh
am  
How: Patient education (verbal and 
written), contacting and involving 
primary and secondary services in the 
screening, referral to other services 
(smokers), follow-up 
What: Lifestyle advice (mainly 
smoking, BP and cholesterol) 
20. Voogdt-Pruis, 
M. et al. (2010) 
The Netherlands 
RCT 701 patients with 
high risk of CVD 
(>10% risk on 
SCORE) 
A + BMI SCORE How: Counselling (Motivational 
Interviewing), self-management support 
and monitoring.  
What: Lifestyle advice (mainly BP, 
total- LDL-cholesterol, BMI and 
smoking). 
21. Fusar-Poli, P. 
et al. (2009) 
Italy 
Cross-
sectional  
123 outpatients 
with functional 
psychosis 
BMI, BP, glucose level, 
alcohol, diet, smoking, 
physical activity 
None NA 
22. Koelewijn-
van Loon, M. et 
al. (2009)  
RCT 
 
615 patients eligible 
for CVR 
management 
please see #15 SCORE please see #17 
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The Netherlands   
23. Pavic, J. et al. 
(2009)  
Croatia 
Discursive 
article 
NA Systolic BP, total-/HDL 
cholesterol ratio, BMI, 
waist and hip 
circumference, heart rate, 
glucose level, smoking, 
alcohol, diet, physical 
activity  
NA NA 
24. Chamney, M. 
et al. (2009) 
UK 
Discursive 
article 
NA Gender, smoking, BP, full 
lipid profile, DM, left 
ventricular hypertrophy 
NA NA 
 
25. Tone, J. et al 
(2009)  
Ireland 
RCT 188 patients with 
type 2 DM  
Weight, BP, glucose level, 
full lipid profile, smoking, 
history of CVD, medication 
None How: Patient education (verbal and 
written) and lifestyle advice, referral to 
GP, follow-up and feedback about 
targets, titration of medication 
(protocolled) 
What: CVR factors 
26. Sol, B. et al. 
(2008)  
The Netherlands 
RCT (part 
of Goessens 
B. et al. 
2006 #31) 
153 patients with 
CVD and with at 
least two 
modifiable risk 
factors 
BMI, WC, BP, history 
(CVD, DM), medication, 
smoking 
 
None How: Life style advice, self-efficacy 
promotion, feedback about targets 
What: CVR factors 
27. Iborra-Moltó, 
C. et al. (2008) 
Spain 
Cross-
Sectional 
89 patients with 
chronic kidney 
disease at 
haemodialysis, with 
at least one criteria 
for metabolic 
syndrome* 
BMI, WC, Triglycerides, 
HDL-cholesterol, FG, renal 
function. 
None NA 
 
28. Drevenhorn, 
E. et al. (2007) 
Sweden 
Pre-test 
post-test 
177 patients with 
hypertension  
Gender, BP, BMI, waist/hip 
ratio,  
renal function, full lipid 
profile, smoking, alcohol, 
physical activity, diet, 
stress, comorbidities, 
medication, metabolic 
syndrome*. 
None How: Patient education (verbal and 
written) and lifestyle advice, follow-up, 
counselling and feedback consultation 
and feedback about targets 
What: CVR factors, effects and side-
effects of medications 
29. Tonstad, S. et 
al. (2007) 
Norway 
RCT 51 patients with 
mild hypertension 
B + BMI, WC, heart rate, 
glucose level, metabolic 
syndrome*, homocysteine, 
fibrinogen, diet, physical 
activity,  
Framingh
am 
How: Self-management promotion, life 
style advice, patients encouraged to 
contact GP 
What: CVR factors (metabolic 
syndrome*, BP, lipid profile and WC) 
30. Hill, J. (2007) 
UK 
Discursive NA Gender, WC, BMI, BP, 
lipids, glucose level, 
smoking, comorbidities 
NA NA, but the recommendation is: 
How: Life style advice, motivation and 
support, referral to other health 
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professionals 
What: CVD factors, mainly obesity 
31. Goessens, B. 
et al. (2006) 
The Netherlands 
RCT 175 patients with 
CVD and with at 
least 2 modifiable 
risk factors 
BMI, BP, medical history, 
medication, smoking, 
alcohol, glucose level, full 
lipid profile, homocysteine 
(or see #26) 
None  How: Life style advice, self-efficacy 
and adherence promotion, follow-up 
and feedback about targets, referral to 
GP 
What: CVR factors (or see #26) 
32. Mainie, P. et 
al. (2005) 
UK 
Cross-
sectional 
563 patients with 
coronary heart 
disease, post-MI 
and/or coronary 
artery bypass  
BMI, BP, full lipid profile, 
glucose level, CRP, diet 
(salt intake), alcohol, 
smoking, physical activity, 
medical family history, 
comorbidities, medication, 
ethnicity 
None How: Life style advice, referrals to 
other professionals, follow-up and 
feedback about targets (depending on 
risk factors and drugs until targets 
being achieved) 
What: CVR factors, medication 
compliance 
33. Ellis, G. & 
Rodger, J. (2005) 
UK 
RCT 205 patients with 
stroke or TIA and 
with at least 1 
modifiable risk 
factor 
BP, smoking, glucose level, 
total-cholesterol 
None How: Patient education (verbal and 
written) and life style advice, patients 
encouraged to contact GP if 
unacceptable levels 
What: CVR factors, medication 
compliance 
A: standard risk assessment to calculate the SCORE (age+gender +smoking+systolic BP+ total-/High Density 
Lipoprotein (HDL) cholesterol ratio); B: standard risk assessment to calculate the Framingham score 
(age+gender+smoking+systolic BP+total Cholesterol+HDL+BP treated with medication); ABPI: Ankle Brachial 
Pressure Index; BP: Blood Pressure; CRP: C-Reactive Protein; CVD: Cardio Vascular Disease; DM: Diabetes 
Mellitus; Full lipid profile: Total-, LDL-, HDL-cholesterol and Triglycerides; Glucose level: includes fasting 
glucose or random glucose, glycaemia or HbA1c; GP: General practitioner; HP: Health Professionals; R: 
Rheumatologist; RA: Rheumatoid arthritis; RCT: Randomized Controlled Trial; TIA: Transient Ischemic Attack; 
WC: Waist circumference; * Metabolic Syndrome components are (Grundy et al. 2004): abdominal obesity (or WC), 
atherogenic dyslipidemia, raised BP, insulin resistance ± glucose intolerance, proinflammatory state, prothrombotic 
state. 
Examples of CV risk assessment and management in patients with IA  
The following section provides case studies from five European countries (England, The Netherlands, 
Denmark, Spain and Portugal), the national guidelines for CVR assessment and management in patients 
with IA and the nurses’ involvement in this task. The examples are based on individual rheumatology 
centres and are therefore not representative for the respective countries.  
The UK 
In the UK, CVR monitoring has been guided by three guidelines (i) BSR/BHPR guideline for the 
management of RA in the first 2 years (Luqmani et al. 2006), (ii) BSR/BHPR guidelines for management 
of RA after the first 2 years (Luqmani et al. 2009), and (iii) NICE guidelines for the management of RA 
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in adults (NICE 2009). The NICE Guidelines (NICE 2009) recommend the assessment of CVR and 
comorbidities amongst other things as a part of a comprehensive annual review for people with RA. The 
recent NICE Quality Standard for RA (Department of Health 2012)(Department of Health 2012) also 
included the comprehensive annual review. Accordingly, rheumatology services across the UK have 
implemented annual reviews within nurse-led clinics, but the evidence of the implementation is only 
starting to emerge especially in nurse-led rheumatology centres (Cornell et al. 2014, Tugnet et al. 2013, 
Gordon et al. 2015) and in primary care (Monk et al. 2013, Forgie et al. 2015, Hider et al. 2015).  
One example of such services is the setup of a nurse-led annual review clinic in Darent Valley Hospital. 
During the clinic appointment (which lasts for 30 minutes) several assessments are carried out including 
disease activity, comorbidities including CVR (using QRISK) as well as falls and fracture risks using 
FRAS and FRAX scores (Palmer and El Miedany 2013, El Miedany et al. 2011). The nurse assesses the 
patient’s functional disability, quality of life, work ability and the possible need for further referral to 
other health care professionals using the multidimensional Patient Reported Outcome Measures 
Questionnaire (El Miedany et al. 2010). Patients identified with increased CVR  are referred to their GP 
or for further assessment and management by a specialised team (Palmer and El Miedany 2013). 
Furthermore, the centre has setup an interactive patient education service (“Managing my heart and 
arthritis”) for patients with IA and CVR which is run by the rheumatology nurse in cooperation with the 
cardiology nurse specialist.  
The Netherlands 
In the Netherlands, CVR assessment and management by nurses take place mainly in primary care 
settings, where practice nurses work closely with GPs, communicating results and supporting them in 
CVR management. This intervention is guided by The Dutch Standard for General Practitioners  
(Huisartsgenootschap 2012) which is based on a multidisciplinary guideline created in 2006  and updated 
in 2011  (Hart and Vaatgroep 2011). Life-style advice concerning weight, smoking and physical activity 
is included for all patients. Medication (antihypertensive or lipid lowering therapy) is indicated for people 
with a Framingham score above 10% and certain other risk factors. High disease activity in people with 
RA is considered a high additional risk. 
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A position paper regarding CVR management published by The Dutch Society for Rheumatology 
(Nurmohamed et al. 2007) states that in patients with RA, CVR (e.g. blood pressure, cholesterol levels) 
should be assessed and registered and appropriate follow up should take place. 
At present, CVR assessment and management are not carried out systematically in people with IA. If the 
patient’s CVR is assessed by rheumatology nurses, it is usually only in people with RA and the SCORE 
tool is used for risk assessment. Patients with an increased CVR are referred to their GP for treatment and 
follow up.  
In Maastricht University Medical Centre, Maastricht, the Netherlands, systematic CVR assessment in 
patients with gout by rheumatologists and nurses has been initiated. In case of an increased Framingham 
score (>10%), the patients are referred to their GP for follow-up. The program is planned to embrace 
patients with RA and Spondyloarthritis (SpA) in the future.  
Denmark 
The Danish Rheumatologists society incorporated CVR assessment and management in their most recent 
guideline (Asmussen 2012) based on the EULAR recommendations (Peters et al. 2010), recent guidelines 
from the Danish Cardiology Association (Hildebrandt et al. 2010) and the Danish Association for General 
Practice (Christensen et al. 2007). Yearly screening for patients with RA is recommended, but there may 
be longer intervals depending on the patient’s risk. The European SCORE model is recommended for risk 
assessment using Total/ HDL-cholesterol ratio (Conroy et al. 2003, Asmussen 2012).  
At King Christian X’s Hospital for Rheumatic Diseases in Graasten, Denmark, nurse-led CVR assessment 
and management for patients with RA was initiated in September 2011 (Primdahl et al. 2013) based on 
the national and EULAR recommendations. Later, patients with polyarthritis, PsA and SpA have been 
included. The nurse has 30 minutes for the consultation including documentation in the patients record 
and in the national rheumatology database, Danbio (Hetland 2011). Apart from CVR assessment, the 
patient’s motivation, support and barriers in everyday life for changes are part of the dialogue with the 
patient. Visual charts are used for pedagogical reasons (Kirby and Machen 2009), but the precise 
calculation of mSCORE or SCORE and BMI are performed electronically in the database. The patients 
are offered relevant pamphlets and a print with the results from the consultation and they are referred for 
follow-up by their GP or community health care centres in case of SCORE ≥5% or single risk factors 
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exceeding defined levels. If the patient’s relatives are present they are invited to take part in the 
consultation as well. The nurses have received education in ischemic CV diseases, the national prevention 
strategies, how to assess risk based on the SCORE model, diet and options for support in the local 
community centres. The entire hospital staff has been trained in Motivational Interviewing (Rollnick 
2009) which is also used in the consultations.  
As Danish GPs are not yet fully aware of the excess risk in patients with IA, risk assessment is still 
considered to be the rheumatologists’ responsibility. In the past couple of years more Danish 
rheumatology departments and practicing rheumatologists have been implementing similar nurse-led 
models while others aim to let the rheumatologists include CVR assessment and management in their 
annual review clinics. 
Spain 
There are variations in rheumatology units across Spain in terms of nursing experiences in CVR 
assessment and management, but with very scarce clinical nursing experience regarding this task. The 
Spanish Rheumatology Society incorporated Recommendations for the management of CVR in patients 
with RA (Martin-Martinez et al. 2014) . In addition, in agreement with the Rheumatology National 
Spanish Society (Gobbo 2013), CVR assessment is one of the reasons for rheumatologists to refer a 
patient to a rheumatology nurse consultation. At present rheumatology nurses in a very few departments 
follow the EULAR recommendations (Peters et al. 2010), using mainly the mSCORE. In our centre 
(Moises Broggi Hospital at Sant Joan Despi, Barcelona), during the rheumatology nursing clinical 
appointment (40 minutes), a CVR assessment is made using the mSCORE (other assessments are also 
made). If a patient is identified with increased CVR, the rheumatology nurse discusses the case with the 
rheumatologist and the patient is either referred to their GP for further follow-up or is referred for further 
assessment and management by a specialized team at the hospital. In addition, patient education 
addressing changes in lifestyle (diet, exercise and more) are provided by the rheumatology team. 
At present, the dissemination and implementation of the new Spanish recommendations for the 
management of CVR in patients with RA (Martin-Martinez et al. 2014) takes place and a new example 
was presented at the EULAR conference in 2015 (Martínez Alberola et al. 2015).  
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Portugal   
In Portugal, there is no national recommendation or guideline for CVR assessment and management or 
monitoring comorbidities in IA patients. CVR assessment and management in rheumatology patients are 
mainly performed by GPs and primary care nurses, following the general international guidelines (Reiner 
et al. 2011, Fifth Joint Task Force of the European Society of Cardiology et al. 2012) and the National 
Health Regulations (Direção-Geral de Saúde 2015, Direção Geral de Saúde 2014). In primary care 
settings, data to calculate the patients’ risk SCORE are requested by computerised clinical records, which 
are updated by GPs and nurses. The systematisation of this task varies between health care facilities, even 
within the same township.  
CVR assessment and management in IA patients are also performed by rheumatologists, but not in an 
integrated and systematic procedure. The national rheumatology database registry (http://www.reuma.pt) 
which is used in the clinic by the majority of rheumatologists, includes all the risk factors needed for 
calculating the SCORE or mSCORE. However in the registry, these factors are not aggregated together to 
ease the calculation of any risk score. In the registry, the only aggregated value that generates a ‘red flag’ 
is an abnormal BMI.  
When rheumatologists identify a recurrent elevated risk factor at the rheumatology department at Centro 
Hospitalar e Universitário de Coimbra, (e.g. hypertension) they may initiate medication, provide brief 
lifestyle advice or refer the patient for follow-up by a cardiologist or GPs. To the best of our knowledge, 
nurses are not yet involved in CVR assessment or management in people with IA in Portugal. 
DISCUSSION  
Our review shows that European nurses undertake CVR assessment and management in many different 
types of patients and in both hospitals and primary health care settings. Overall the CVR assessments 
include history taking (family history, smoking, alcohol, diet and physical activity) and measurements 
(BMI, waist circumference, BP, blood lipids and glucose level). The evidence regarding the use of waist 
circumference or waist-hip ratio to predict CVR instead of BMI is not clear, but all three measures are 
highly associated to CV disease (Perk et al. 2013) and waist circumference may be useful to illustrate an 
abdominal weight problem to the patient. The WHO thresholds for waist circumference in European 
populations are based on Caucasians and are widely used (Perk et al. 2013), but they should be adjusted 
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according to ethnic group (Hill 2007, Tillin et al. 2014). SCORE and Framingham were the most used 
tools to calculate the patients’ CVR, but other tools were also used.  
Despite the fact that patients with RA have an increased risk similar to that in diabetes (van Halm et al. 
2009, Peters et al. 2009), both our review, the country-specific descriptions and other studies indicate that 
the implementation of CVR assessment and management in patients with IA is still scarce irrespective of 
whether this role is undertaken by rheumatologists, GPs or nurses (Peters and Nurmohamed 2013, Monk 
et al. 2013, Garcia-Diaz and Corominas 2013). Only two of the included studies described nurse-led CVR 
assessment and management in rheumatology (Primdahl et al. 2013, Dougados et al. 2014).  
As indicated by the country specific descriptions there are unsolved decisions regarding who should 
perform CVR assessment and management and how this should be organized and this is supported in the 
literature (Dessein and Semb 2013, van den Oever et al. 2013). Furthermore the rheumatologists may find 
it difficult to allocate time for CVR assessment and they may not feel that CVR management is part of 
their core tasks. These issues may explain part of the inertia to implement systematic screening in patients 
with IA. A French multicentre RCT reported the first results from comprehensive nurse-led screening of 
comorbidities including CV disease in patients with RA with a positive impact on several CVR outcomes 
(Dougados et al. 2014), but more evidence is needed regarding the effectiveness of CVR screening and 
management.  
It is important to acknowledge that pharmacological treatment to control the inflammation is a very 
important part of the efforts needed to achieve a reduced CVR (van den Oever et al. 2013, Choy et al. 
2014). This is an important task for the rheumatologist or nurses where they undertake extended roles. 
The initiation and titration of antihypertensive and lipid lowering therapy in patients with increased CVR 
can be managed in cooperation between the rheumatology nurse and the rheumatologist or by referral to 
the patient’s GP. Also, nurses are described to have an important role in discussing current medication 
and adherence issues with the patient.  
An unsupportive social environment can have a strong negative influence on the individual’s health 
related behaviour and socially deprived persons may be less capable of becoming actively engaged in 
their own health (Andric and Vuletic 2012). The nurse should avoid focusing only on the individual 
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choice and responsibility as CVR depends on socio-economic status as well, in terms of educational level 
and income, job and living conditions in a broader sense (Perk et al. 2013, Vallgarda 2011). 
In order to avoid a ‘tick the box’ culture or becoming just ‘risk police’ (Boase et al. 2012), nurses need to 
engage with the individual patient and help support the patient’s risk perception and make CVR 
meaningful to patients. This requires that nurses explore the patient’s social context, emotions, 
preferences and motivation, regarding life-style modifications and the barriers and possibilities for 
changes. Furthermore the nurse should try to empower the patient, individualise the education and respect 
the patient’s own choices as described in some of the included studies (Boase et al. 2012, Andric and 
Vuletic 2012, Pavic et al. 2009, Chamney et al. 2009, Sol et al. 2008).  
Appropriate training has been shown to affect the counselling to become patient-centred and focused 
(Drevenhorn et al. 2009). Training of the nurses who perform CVR assessment and management should 
include how to assess the different risk factors in order to achieve reliable measures, how to calculate a 
risk score, risk management including a patient centred approach and theoretical health pedagogy for risk 
communication and how to motivate and support the patient to achieve the goals they would like to 
pursue. While initial training is important, other measures (such as further training) should be put in place 
in order to prevent errors. A Dutch study reported that despite 75 minutes training, nurses made small but 
important errors in risk calculation of high risk patients; errors that could lead to missed opportunities for 
risk-reducing interventions (Koelewijn-van Loon et al. 2011). In the Danish study, the risk calculation 
(SCORE) was performed electronically (Primdahl et al. 2013) and thus manual mistakes could be 
prevented although emphasis would then need to be put on preventing entry errors.  
Strengths and limitations of the study 
This was a limited systematic literature review; therefore there will probably be relevant studies that have 
not been included. Also there may be additional content of the nurses risk assessment and management 
which was not described in the included studies. The aim of our literature search was to explore nurses’ 
role in assessing and managing CVR in Europe, in order to suggest topics for practice development and 
research in this area regarding persons with IA. We excluded non-European articles, which could be seen 
as another limitation, but knowing that the nurses’ education, skills and how health care is organized 
across Europe varies, we did not want to add further differences. Since we were interested in the 
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descriptions of risk assessment and management, rather than effectiveness of interventions, we did not 
perform a formal assessment of the quality or risk of bias of the included studies. Lastly, the examples 
given in our country case studies may not be generalizable since clinical practice varies from centre to 
centre within each country. The main strength of this study is having an international collaboration with 
different perspectives and real examples of nurses’ role in CVR assessment and management. The results 
of this study could form a strong basis for future research.  
Implications for future research 
Further research is needed to investigate the clinical effectiveness and cost-effectiveness of nurse-led risk 
assessment and management in reducing patients’ risk for development of diabetes and CV disease. 
Secondly, further research is required to assess how risk can be communicated in a meaningful way to the 
patient and how often (Waldron et al. 2011). Future research in this area needs to provide accurate 
descriptions of (i) how the nurses are trained in undertaking CVR assessment and management, (ii) which 
risk factors are assessed by the nurses, (iii) how nurses assess the CV risk factors and (iv), how the nurses 
communicate risk, (v) how nurses manage CV risk and (vi) how nurses and the rheumatologists 
collaborate with the GPs, practice nurses and other health professionals to optimise CVR assessment and 
management. Screening for risk of a disease is likely to lead to both positive and negative reactions in the 
patients. So far only one recent study has explored RA patients’ experiences from participation in nurse-
led CVR (Frølund and Primdahl 2015). Therefore more qualitative studies of the patients’ experiences 
from participation in different versions of CVR assessment and management and their risk perception in 
IA are needed. Lastly, the effectiveness of telemedicine and ubiquitous computing (such as smartphone 
apps) in risk assessment and management for people with IA needs to be explored.  
CONCLUSION  
European nurses perform assessment of known CVR factors (BP, BMI, waist circumference, glucose and 
lipid-profile, adherence to medication, unhealthy diet, physical inactivity, excess alcohol use and 
smoking) and calculate the patient’s risk score in different groups of patients.  
Risk management differ from brief advice to long-term follow-up. The nurses focus on patient 
involvement, adherence to medications, preferences, barriers, motivation and resources for life-style 
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modifications. The nurses refer the patients for further follow up by their rheumatologist, GP or resources 
in primary care. Antihypertensive, lipid lowering and diabetes medications can be initiated and titrated by 
the rheumatologist, the GP or nurses with extended roles depending on the national context.  
With appropriate training it is considered to be a highly relevant task for rheumatology nursing to perform 
CVR assessment, to communicate and manage CVR and provide relevant patient education, especially in 
patients with IA. Further studies are needed to assess the patients’ perspective, effectiveness and cost-
effectiveness of nurse-led CVR assessment and management in reducing patients’ risk for development of 
diabetes and CV disease. 
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